O Trademark

Trademark Overview

On Wednesday, May 22, 2024, a trademark application was filed for O with the United States Patent and Trademark Office. The USPTO has given the O trademark a serial number of 98562994. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, March 3, 2025. This trademark is owned by Laboratoire HRA Pharma SAS. The O trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, preparations for contraception; oral contraceptives
o

General Information

Serial Number98562994
Word MarkO
Filing DateWednesday, May 22, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, March 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of a white "O" against a teal background.
Goods and ServicesPharmaceutical products, namely, preparations for contraception; oral contraceptives
Indication of Colors claimedThe colors teal and white are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 22, 2024
Primary Code005
First Use Anywhere DateMonday, March 18, 2024
First Use In Commerce DateMonday, March 18, 2024

Trademark Owner History

Party NameLaboratoire HRA Pharma SAS
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressChâtillon 92320
FR

Trademark Events

Event DateEvent Description
Wednesday, May 22, 2024NEW APPLICATION ENTERED
Wednesday, November 27, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, November 27, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 3, 2024ASSIGNED TO EXAMINER
Friday, December 6, 2024NON-FINAL ACTION WRITTEN
Friday, December 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 6, 2024NON-FINAL ACTION E-MAILED
Monday, January 13, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 13, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 13, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 29, 2025EXAMINER'S AMENDMENT ENTERED
Wednesday, January 29, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 29, 2025EXAMINERS AMENDMENT E-MAILED
Wednesday, January 29, 2025EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 12, 2025EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 12, 2025EXAMINER'S AMENDMENT ENTERED
Wednesday, February 12, 2025EXAMINERS AMENDMENT E-MAILED
Wednesday, February 12, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 18, 2025TEAS AMENDMENT OF USE RECEIVED
Tuesday, February 18, 2025USE AMENDMENT FILED
Tuesday, February 18, 2025AMENDMENT TO USE PROCESSING COMPLETE
Monday, March 3, 2025USE AMENDMENT ACCEPTED
Monday, March 3, 2025NON-FINAL ACTION E-MAILED
Monday, March 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 3, 2025NON-FINAL ACTION WRITTEN

Related Keywords

oral contraceptives contraception preparations products namely pharmaceutical